Product Code: 4606
Global therapeutic vaccines market is expected to grow at a double digit CAGR during the forecast period on account of increasing awareness in the population about prevalence of fatal and chronic diseases. Moreover, on account of increasing demand from consumers, 120 new vaccines are also anticipated to be introduced globally by different multinational companies, thereby driving the market. Since vaccines are prepared for a special type of disease, it can be said that this market is a demand-based market.
Global therapeutic vaccines market is segmented on the basis of type, product, technology, delivery mechanism, end user, company and region. Type segment is further segregated into addiction vaccines, auto immune disease vaccines, neurological disease vaccines, cancer vaccines, infectious disease vaccine and others. Auto immune disease vaccines held the largest market share in 2019 as auto immune diseases are responsible for majority of deaths all over the world.
In terms of regional analysis, Asia-Pacific is anticipated to grow at the highest rate until 2025 owing to increasing patient awareness and improving healthcare infrastructure. Moreover, favorable regulations and initiatives taken by the government in the economies present in the region are positively impacting the growth of the market.
Leading players in the global therapeutic vaccines market include Sanofi Pasteur SA de CV, Intellect Neurosciences Inc, Agenus Inc, Celtic Pharma Holdings Advisors LLC, Novartis AG, Bavarian Nordic A/S, Transgene SA, Argos Therapeutics Inc, Celldex Therapeutics Inc, CureVac GmbH, etc. The companies operating in the global therapeutic vaccines market are adoption inorganic and organic growth strategies to increase their share in the market.
Years considered for this report:
Historical Years: 2015-2018
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2021-2025
XXXXXObjective of the StudyYYYYY:
- To analyze and forecast the market size of global therapeutic vaccines market.
- To classify and forecast global therapeutic vaccines market based on type, product, technology, delivery mechanism, end user, company and region.
- To identify drivers and challenges for global therapeutic vaccines market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global therapeutic vaccines market.
- To conduct pricing analysis for global therapeutic vaccines market.
- To identify and analyze the profile of leading players operating in global therapeutic vaccines market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.
TechSci Research calculated the market size of global therapeutic vaccines market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
XXXXXKey Target AudienceYYYYY:
- Therapeutic vaccines manufacturers, suppliers, distributors and other stakeholders
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to therapeutic vaccine
- Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
XXXXXReport ScopeYYYYY:
In this report, global therapeutic vaccines market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Antigen Vaccine
Dendritic Cell Vaccine
DNA Vaccines
Tumor Cell Vaccine
Addiction Vaccines
Auto Immune Disease Vaccines
Neurological Disease Vaccines
Cancer Vaccines
Infectious Disease Vaccine
Others
Autologous Vaccines
Allogeneic Vaccines
- Market, By Delivery Mechanism:
Nasal
Electroporation
Private Hospitals
Government Hospitals
Specialty Clinics
Asia-Pacific
- China
- India
- Japan
- South Korea
- Singapore
- Australia
Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
North America
- United States
- Mexico
- Canada
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
XXXXXCompetitive LandscapeYYYYY
Company Profiles: Detailed analysis of the major companies present in global therapeutic vaccines market.
XXXXXAvailable CustomizationsYYYYY:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
2. Research Methodology
3. Impact of COVID 19 on Global Therapeutic Vaccines Market
4. Voice of Customers
5. Executive Summary
6. Global Therapeutic Vaccines Market Outlook
- 6.1. Market Size & Forecast
- 6.2. Market Share & Forecast
- 6.2.1. By Type (Antigen Vaccine, Dendritic Cell Vaccine, DNA Vaccines, Tumor cell vaccine)
- 6.2.2. By Product (Addiction Vaccines, Auto Immune Disease Vaccines, Neurological Disease Vaccines, Cancer Vaccines, Infectious Disease Vaccine, Others)
- 6.2.3. By Technology (Autologous Vaccines, Allogeneic Vaccines)
- 6.2.4. By Delivery Mechanism (Nasal, Electroporation)
- 6.2.5. By End User (Private Hospitals, Government Hospitals, Specialty Clinics)
- 6.2.6. By Company (2019)
- 6.2.7. By Region
- 6.3. Market Attractiveness Index
7. Asia-Pacific Therapeutic Vaccines Market Outlook
- 7.1. Market Size & Forecast
- 7.2. Market Share & Forecast
- 7.2.1. By Product Type
- 7.2.2. By Technology
- 7.2.3. By End User
- 7.2.4. By Country
- 7.3. Asia-Pacific: Country Analysis
- 7.3.1. China Therapeutic Vaccines Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Product Type
- 7.3.1.2.2. By Technology
- 7.3.1.2.3. By End User
- 7.3.2. India Therapeutic Vaccines Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Product Type
- 7.3.2.2.2. By Technology
- 7.3.2.2.3. By End User
- 7.3.3. Japan Therapeutic Vaccines Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Product Type
- 7.3.3.2.2. By Technology
- 7.3.3.2.3. By End User
- 7.3.4. South Korea Therapeutic Vaccines Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Product Type
- 7.3.4.2.2. By Technology
- 7.3.4.2.3. By End User
- 7.3.5. Singapore Therapeutic Vaccines Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Product Type
- 7.3.5.2.2. By Technology
- 7.3.5.2.3. By End User
- 7.3.6. Australia Therapeutic Vaccines Market Outlook
- 7.3.6.1. Market Size & Forecast
- 7.3.6.2. Market Share & Forecast
- 7.3.6.2.1. By Product Type
- 7.3.6.2.2. By Technology
- 7.3.6.2.3. By End User
8. Europe Therapeutic Vaccines Market Outlook
- 8.1. Market Size & Forecast
- 8.2. Market Share & Forecast
- 8.2.1. By Product Type
- 8.2.2. By Technology
- 8.2.3. By End User
- 8.2.4. By Country
- 8.3. Europe: Country Analysis
- 8.3.1. France Therapeutic Vaccines Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Product Type
- 8.3.1.2.2. By Technology
- 8.3.1.2.3. By End User
- 8.3.2. Germany Therapeutic Vaccines Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Product Type
- 8.3.2.2.2. By Technology
- 8.3.2.2.3. By End User
- 8.3.3. United Kingdom Therapeutic Vaccines Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Product Type
- 8.3.3.2.2. By Technology
- 8.3.3.2.3. By End User
- 8.3.4. Italy Therapeutic Vaccines Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Product Type
- 8.3.4.2.2. By Technology
- 8.3.4.2.3. By End User
- 8.3.5. Spain Therapeutic Vaccines Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Product Type
- 8.3.5.2.2. By Technology
- 8.3.5.2.3. By End User
9. North America Therapeutic Vaccines Market Outlook
- 9.1. Market Size & Forecast
- 9.2. Market Share & Forecast
- 9.2.1. By Product Type
- 9.2.2. By Technology
- 9.2.3. By End User
- 9.2.4. By Country
- 9.3. North America: Country Analysis
- 9.3.1. United States Therapeutic Vaccines Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Product Type
- 9.3.1.2.2. By Technology
- 9.3.1.2.3. By End User
- 9.3.2. Mexico Therapeutic Vaccines Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Product Type
- 9.3.2.2.2. By Technology
- 9.3.2.2.3. By End User
- 9.3.3. Canada Therapeutic Vaccines Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Product Type
- 9.3.3.2.2. By Technology
- 9.3.3.2.3. By End User
10. South America Therapeutic Vaccines Market Outlook
- 10.1. Market Size & Forecast
- 10.2. Market Share & Forecast
- 10.2.1. By Product Type
- 10.2.2. By Technology
- 10.2.3. By End User
- 10.2.4. By Country
- 10.3. South America: Country Analysis
- 10.3.1. Brazil Therapeutic Vaccines Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Product Type
- 10.3.1.2.2. By Technology
- 10.3.1.2.3. By End User
- 10.3.2. Argentina Therapeutic Vaccines Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Product Type
- 10.3.2.2.2. By Technology
- 10.3.2.2.3. By End User
- 10.3.3. Colombia Therapeutic Vaccines Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Product Type
- 10.3.3.2.2. By Technology
- 10.3.3.2.3. By End User
11. Middle East and Africa Therapeutic Vaccines Market Outlook
- 11.1. Market Size & Forecast
- 11.2. Market Share & Forecast
- 11.2.1. By Product Type
- 11.2.2. By Technology
- 11.2.3. By End User
- 11.2.4. By Country
- 11.3. MEA: Country Analysis
- 11.3.1. South Africa Therapeutic Vaccines Market Outlook
- 11.3.1.1. Market Size & Forecast
- 11.3.1.2. Market Share & Forecast
- 11.3.1.2.1. By Product Type
- 11.3.1.2.2. By Technology
- 11.3.1.2.3. By End User
- 11.3.2. Saudi Arabia Therapeutic Vaccines Market Outlook
- 11.3.2.1. Market Size & Forecast
- 11.3.2.2. Market Share & Forecast
- 11.3.2.2.1. By Product Type
- 11.3.2.2.2. By Technology
- 11.3.2.2.3. By End User
- 11.3.3. UAE Therapeutic Vaccines Market Outlook
- 11.3.3.1. Market Size & Forecast
- 11.3.3.2. Market Share & Forecast
- 11.3.3.2.1. By Product Type
- 11.3.3.2.2. By Technology
- 11.3.3.2.3. By End User
12. Market Dynamics
- 12.1. Drivers
- 12.2. Challenges
- 12.3. Porter's Five forces challenge
13. Market Trends & Developments
14. Competitive Landscape
- 14.1. Competition Outlook
- 14.2. Players Profiled (Leading Companies)
- 14.2.1. Sanofi Pasteur SA de CV
- 14.2.2. Intellect Neurosciences Inc
- 14.2.3. Agenus Inc
- 14.2.4. Celtic Pharma Holdings Advisors LLC
- 14.2.5. Novartis AG
- 14.2.6. Bavarian Nordic A/S
- 14.2.7. Transgene SA
- 14.2.8. Argos Therapeutics Inc
- 14.2.9. Celldex Therapeutics Inc
- 14.2.10. CureVac GmbH
15. Strategic Recommendations
16. About Us & Disclaimer
